Approach and management of checkpoint inhibitor-related immune hepatitis

Aravind Sanjeevaiah, Thomas Kerr, Muhammad Shaalan Beg

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immunehepatitis.

Original languageEnglish (US)
Pages (from-to)220-224
Number of pages5
JournalJournal of Gastrointestinal Oncology
Issue number1
StatePublished - Feb 1 2018


  • Gastrointestinal cancers
  • Immune checkpoint inhibitors
  • Immune-mediated toxicity
  • Immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology


Dive into the research topics of 'Approach and management of checkpoint inhibitor-related immune hepatitis'. Together they form a unique fingerprint.

Cite this